Biomedical subjects

M G Young

Publications and source records attributed to M G Young.

At least 19 recordsLinked to original sources

PubMed2005

Effect of sow parity and weight at service on target maternal weight and energy for gain in gestation.

The objective of this study was to evaluate targeted maternal weight gains in sows by parity group during gestation. Weight and backfat gains during gestation by parity, weight, and backfat groups also were analyzed. The data evaluated were a subset (374 sows) of a larger experiment that compared three methods of feeding sows during gestation on weight and backfat gains and subsequent reproductive performance. Feed allowances were based on modeled calculations of energy and nutrient requirements to achieve target sow maternal weight and backfat gains. Actual backfat gain for gilts and sows was regressed on maternal weight gain and estimated energy available for gain. The regression equations were then used to predict maternal weight gains for target backfat gains for three parity groups (gilts, Parity 1 and 2 sows, and Parity 3 and older sows). For gilts and Parity 1 and 2 sows, much greater target maternal weight gains are required to achieve 6 and 9 mm of backfat gain, whereas Parity 3 and older sows require maternal weight gains similar to those targeted to achieve the desired backfat gain. Given similar energy intake levels above maintenance, gilts gained more weight than multiparous sows, as gain was based more on protein and less on fat and thus was more efficient. Gilts required more maternal weight gain than sows to achieve similar backfat gains due to the higher protein and low fat contents of gain in younger, lighter sows compared with older parity sows. Low-backfat sows that needed to gain large amounts of backfat failed to achieve these large gains. We speculate this failure may be due to lower tissue insulation levels with the low backfat levels and higher activity levels of these sows compared with high-backfat sows. It seems that both parity and weight are individually important factors that influence energy and nutrient requirements for gestation in the modern sow.

Adipose Tissue↗

PubMed2004

Comparison of three methods of feeding sows in gestation and the subsequent effects on lactation performance.

A total of 684 sows from breeding groups over 6 wk was used to compare three methods of feeding during gestation on gestation and lactation performance. Control gilts and sows were fed according to body condition based on a scale of 1 to 5 (1 = thin, 5 = fat). Sows were visually assessed for body condition at breeding and were assigned a daily feed allowance to achieve a BCS of 3 at farrowing. Treatment 2 used feeding levels based on backfat thickness (measured between d 0 and 5 after breeding) and weight at weaning for sows or service for gilts. Feed allowance was calculated to achieve a target backfat of 19 mm at farrowing, and remained constant from d 0 to 101 of gestation. Feed allowances were based on modeled calculations of energy and nutrient requirements to achieve target sow maternal weight and backfat gains. Treatment 3 was identical to Treatment 2, except that feeding pattern was altered for thin sows and gilts (<15 mm at service) in an attempt to reach 19 mm by d 36 of gestation. Sows were weighed at the previous weaning, and gilts were weighed at service, with both weighed again between d 112 and 114 of gestation. Backfat was measured between d 0 and 5, and again between d 108 and 113 of gestation. At farrowing, sows on Treatments 2 and 3 had 19 and 19.1 mm of backfat, respectively, whereas control sows tended to have greater (P < 0.07) backfat (20 mm). On average, sows targeted to gain 6 to 9 mm of backfat failed to reach target gains regardless of feeding method. Feeding sows in gestation based on backfat (Treatments 2 and 3) resulted in a numerically higher proportion of sows in the target backfat range of 17 to 21 mm (40.2, 53.3, and 52.6% for control and Treatments 2 and 3, respectively) at farrowing and a numerically lower percentage of fat sows (>21 mm), but no difference in the percentage of thin sows (<17 mm) compared with feeding based on body condition. In conjunction with this observation, sows fed based on BCS were fed higher (P < 0.05) feeding levels in gestation than were sows fed based on backfat depth. Gestation feeding method had no effect on performance during lactation. Feed intake in lactation was lower (P < 0.05) for high backfat sows (>21 mm) at farrowing compared with sows with <21 mm. The high proportion of sows in the optimal backfat category demonstrates that feeding based on backfat and BW has potential for facilitating more precise feeding during gestation.

Adipose Tissue↗

PubMed2004

Influence of Carnichrome on the energy balance of gestating sows.

Twelve multiparous sows with an average initial weight of 182 kg were used in a randomized complete block design to determine the effects of feeding Carnichrome (50 mg of carnitine and 200 microg of chromium picolinate per kilogram of feed, as fed) on energy and nitrogen utilization in early, mid-, and late gestation. All sows were fed a diet with or without Carnichrome for the preceding 28-d lactation, the weaning-to-estrus period, and for the duration of gestation. Daily feeding allowances over pregnancy were based on calculated energy and nutrient requirements to achieve a target sow maternal weight gain of 20 kg and remained constant throughout gestation. Heat production (HP) and its partitioning (activity, thermic effect of feeding short term [TEFst], basal) were determined in early (wk 5 or 6), mid- (wk 9 or 10), and late (wk 14 or 15) pregnancy using indirect calorimetry. Net maternal weight gain and total number of fetuses averaged 21.6 kg and 16.4, respectively. Organic matter and energy digestibility for the Carnichrome diet was greater (P < 0.05), which resulted in greater DE and ME contents (0.6%, P < 0.05) compared with the control diet. The digestibility coefficient of energy in the current experiment for a typical corn and soybean meal diet (92%) was greater than that predicted from DE values of corn and soybean meal in feeding tables (88%). Carnichrome had no effect on total HP, energy retained as protein or lipid, and maternal energy retention in early, mid-, or late gestation. Heat production in late gestation increased linearly (4.0 kJ/[kg BW0.75 x d]) for each additional day from d 90 to 110, despite the reduction of ME intake per unit of BW0.75. Metabolizable energy requirement for maintenance was 405 kJ/(kg BW0.75 x d). On average, activity HP was 116 kJ/(kg BW0.75 x d), which was equivalent to 20% of ME intake; however, this value ranged from 11 to 37% between sows, which corresponds to duration of standing ranging from 210 to 490 min/d. Energy cost of standing activity averaged 0.30 kJ/(kg BW0.75 x min). In conclusion, Carnichrome had no effect on the components of heat production and maternal weight gain during gestation, although it improved energy and organic matter digestibility of the diet.

Animals↗

PubMed2000

The role of nurses in AIDS care regarding voluntary euthanasia and assisted suicide: a call for further dialogue.

The role of nurses in AIDS care regarding voluntary euthanasia and assisted suicide: a call for further dialogue Because of the nature of their work, nurses are directly involved with terminally ill patients and the problems associated with the decision to hasten death through voluntary euthanasia or assisted suicide (VE/AS). An anonymous survey delivered to nurses working in HIV/AIDS settings in Canada was used to analyse nurses' experiences and attitudes regarding VE/AS. An emergent analysis of 22 nurses' responses to an open-ended prompt appearing at the end of the survey reveals that nurses: support death-hastening practices; believe that legislation for these practices needs to be established; are wary of the potential abuse of VE/AS; and believe that further discussion on end-of-life issues is imperative. Their caring role in the health care setting places nurses in key positions to stimulate discussion in this area.

Acquired Immunodeficiency Syndrome↗

PubMed1998

Euthanasia and assisted suicide: a survey of registered social workers in British Columbia.

This anonymous postal survey explores the attitudes and experiences concerning voluntary euthanasia (VE) and assisted suicide (AS) held by professionally registered members of the British Columbia Association of Social Workers. Social workers determine only a minor moral distinction between VE and AS and a large majority believe both acts should be legal, in certain circumstances (VE 75.9 per cent; AS 78.2 per cent). Approximately 80.0 per cent feel that social workers should be involved in social policy development concerning VE and AS, and, if such acts were to be legal, 70.0 per cent believe social workers should be involved in the decision making process with clients. Over 21.0 per cent of all social workers and nearly 40.0 per cent of social workers with medical employers have been consulted by a patient about VE or AS. Six respondents (1.1 per cent) reported assisting the death of a patient by VE. None had involvement in AS. Further research and education is required to better inform social work practice in this ethical area. Given the unique position of social workers in health care, they should, for the benefit of patients, families, and physicians, actively participate in the discussion concerning end of life decisions.

Attitude of Health Personnel↗

PubMed1997

High throughput analysis and purification in support of automated parallel synthesis.

Rapid reverse-phase analytical and preparative HPLC methods have been developed for application to parallel synthesis libraries. Gradient methods, short columns, and high flow rates allow analysis of over 300 compounds per day on a single system, or purification of up to 200 compounds per day on a single preparative system. Hardware and software modifications allow continuous unattended use for maximum efficiency and throughput.

Automation↗

PubMed1996

Hydroxamic acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.

The rational design, synthesis, and activity of novel, hydroxamic acid-based, collective bisubstrate analog inhibitors of farnesyl protein transferase (FPT) is described. This class of compounds differ structurally from the conventional FPT inhibitors by being non-sulfhydryl and by being bisubstrate based rather than peptide or FPP derived inhibitors. Whereas replacement of the sulfhydryl group of tetrapeptide CVLS (I50 = 1 microM) by an N-methylhydroxamic acid had a deleterious effect (10, I50 > 360 microM), moderate inhibition was realized with 16 (I50 = 42.5 microM), a bisubstrate analog involving anchorage of farnesyl and tripeptide groups by a hydroxamic acid-embedded linker. Starting from 16, a 1 order of magnitude improvement in in vitro potency was obtained by optimization of the linker (20, I50 = 4.35 microM). An additional 13-fold enhancement was achieved by substituting the tripeptide moiety VLS in 20 by VVM (23, I50 = 0.33 microM). The dependence of these inhibitors on their peptide and farnesyl subunits is suggestive of their bisubstrate nature. Compound 23 (I50 = 0.33 microM) is 2 orders of magnitude better in activity compared to the initial lead 16 [I50 = 42.5 microM) and is effective in blocking prenylation of protein in whole cells including p21ras.

3T3 Cells↗

PubMed1995

Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.

The rational design, synthesis, and biological activity of phosphonyl- and phosphinyl-linked bisubstrate analog inhibitors of the enzyme Ras farnesyl protein transferase (FPT) are described. The design strategy for these bisubstrate inhibitors involved connection of the critical binding components of the two substrates of FPT (ras protein and farnesyl pyrophosphate, FPP) through a phosphonyl- or phosphinyl-bearing linker. Compound 14, the first example in this series, was found to be a potent FPT inhibitor (I50 = 60 nM). A further 15-fold enhancement in activity was observed upon replacement of the VLS tripeptide sequence in 14 with VVM (15, I50 = 6 nM). The phosphinic acid analog 16 (I50 = 6 nM) was equiactive to phosphonic acid 15. Compounds 14-16 afforded 1000-fold selectivity for FPT against the closely related enzyme geranylgeranyl protein transferase type I, GGT-I [14, I50(GGT-I) = 59 microM; 15 I50(GGT-I) = 10 microM; 16 I50(GGT-I) = 21 microM]. Methyl and POM ester prodrugs 17-19 were prepared and evaluated in whole cell assays and appear to block ras-induced cell transformation, as well as colony formation in soft agar. A distinctive feature of this novel class of potent and selective bisubstrate FPT inhibitors is that they are non-sulfhydryl in nature.

3T3 Cells↗

PubMed1995

Gender-, side- and site-dependent variations in human perioral spatial resolution.

Twenty-eight right-handed, young adults participated in a sensory testing experiment to evaluate spatial resolution at 10 positionally matched sites on the right- and left-hand sides of the face. An adaptive psychophysical (i.e. tracking) procedure was used to estimate the threshold spatial separation for perceiving two points of contact at each site. Estimates of the threshold at one site on both sides of the face were also obtained with a method-of-limits procedure similar to that employed for clinical evaluation of patients. In addition, each individual was asked to rate (i) his(her) overall facial sensitivity to touch and (ii) the degree to which he(she) could discern subtle changes in lip, cheek and chin position during speech, chewing and facial expression. Analysis of the estimates of the threshold separation obtained with the tracking procedure revealed a significant effect of gender (p < 0.04) and of site (p < 0.001). Females were more spatially sensitive than males: average threshold separations were 1.55 mm less. Most notably, the threshold increased ninefold with distance posterolaterally from the oral opening. The vermilion of the upper lip was the most spatially sensitive site (population geometric mean = 2.4 mm) and the preauricular skin the least spatially sensitive site (20.9 mm). Significant effects of side and of interactions among gender, side and site were not observed. The estimates obtained with the method-of-limits procedure were very similar to those obtained with the tracking procedure: the latter were 0.67 mm less on the average. Individuals' ratings of overall facial sensitivity to touch were similar for males and females (p > 0.70). Females, however, reported greater ability to discern subtle changes in lip, cheek and chin position than males (p < 0.03). The ratings of this sensory function correlated negatively with the estimates of the threshold separation on the vermilion of the upper lip (p < 0.03).

Adaptation, Physiological↗

PubMed1992

Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.

A series of racemic (1 alpha (E), 2 beta, 3 alpha)-1-[2,3-bis(hydroxymethyl)cyclobutyl]-5-(2-halovinyl)uracils was synthesized and evaluated in cell culture. The bromovinyl, iodovinyl, and chlorovinyl analogues, 13, 15, and 16, respectively, are all potent inhibitors of varicella zoster virus (VZV), but are less inhibitory to the replication of human cytomegalovirus (HCMV) and herpes simplex viruses 1 and 2 (HSV-1, HSV-2). The excellent anti-VZV activities of 13, 15, and 16 coupled with their virtual inability to inhibit WI-38 cell growth indicate high in vitro therapeutic indices. VZV thymidine kinase readily converts these compounds to their respective monophosphates but not to their corresponding diphosphates. Compound 13a, the (1'R) enantiomer of the bromovinyl analogue 13, was also synthesized, and its potency is comparable to that of the racemate. A lower homologue 14, (1 alpha (E),2 beta, 3 alpha)-1-[2-hydroxy-3-(hydroxymethyl)cyclobutyl]-5- (2-bromovinyl)uracil, was found to be inactive against VZV, HCMV, HSV-1, and HSV-2.

Antiviral Agents↗

PubMed1989

Surveillance evaluation for the elderly.

Using a medical, social, and functional assessment form, we found several measures which were reliably associated with a criterion of impending mortality; activities of daily living were most highly correlated, medical assessment and services needed were correlated less strongly, but visual impairment and the cumulative total of all measures were the best predictors (r = .42).

Activities of Daily Living↗

PubMed1989

Reporting peer review actions to the Texas State Board of Medical Examiners.

This article originally was prepared for presentation at the 1988 Texas Health Law Conference, Nov 4, 1988, in Austin. It appears this month in Texas Medicine to emphasize the importance of state and federal laws that require reporting of certain peer review actions by hospitals, medical societies, and other organizations to the Texas State Board of Medical Examiners (TSBME). The author, Michael G. Young, is staff counsel for the TSBME. He formerly was staff attorney and director, Office of Medical Ethics, at Texas Medical Association.

Humans↗

PubMed1988

Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.

(R,S)-9-(3-hydroxy-2-phosphonomethoxypropyl)guanine [(R,S)-HPMPG] exhibits broad spectrum antiviral activity with an ED50 of less than 1 microM against herpes simplex virus (HSV) types 1 and 2, varicella zoster virus, human cytomegalovirus (HCMV) and vaccinia in plaque reduction assays. Wild type HSV-2 and its thymidine kinase deficient variant are equally sensitive to (R,S)-HPMPG. (R,S)-HPMPG is 100-fold more potent than acyclovir (ED50 = 0.45 microM vs. 44 microM, respectively) against HCMV in cell culture, and 10-fold more active than acyclovir in extending survival time in mice intraperitoneally infected with 70 LD50 HSV-1. However, (R,S)-HPMPG is toxic when administered repeatedly at 44 mg/kg/day in uninfected adult mice. The diphosphoryl derivative of HPMPG was enzymatically synthesized and is a competitive inhibitor of HSV-1 DNA polymerase relative to dGTP (K1 = 0.03 microM). HPMPG-PP is 70-fold less active at inhibiting HeLa DNA polymerase alpha than HSV-1 DNA polymerase. At concentrations between 0.3 and 1.5 microM (R,S)-HPMPG inhibited HSV-1 DNA replication greater than or equal to 50% in infected cells as measured by nucleic acid hybridization. Consistent with inhibition of viral DNA synthesis, 6 to 30 microM (R,S)-HPMPG reduces late viral polypeptide synthesis in HSV-1 infected cells. These data indicate that (R,S)-HPMPG is a thymidine kinase independent broad spectrum antiviral drug which is capable of inhibiting viral DNA polymerase.

Acyclovir↗

PubMed1987